Latest Animas Corporation Stories
HIGH WYCOMBE, England, July 21, 2011 /PRNewswire/ -- Using the waterproof* Animas(R) Vibe(TM) Insulin Pump and CGM System, People with Diabetes to Participate in Channel Swim Relay Six swimmers congregate along the Dover coastline today, to participate in a 17-hour relay swim across the English Channel to France.
WEST CHESTER, Pa., June 2, 2011 - Animas Corporation announced today the receipt of CE Mark approval for AnimasÂ® Vibe(TM), the first and only continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4(TM) CGM technology.
WEST CHESTER, Pa., May 11, 2011 /PRNewswire/ -- Animas Corporation and LifeScan, Inc., both members of the Johnson & Johnson Family of Diabetes Companies, today announced plans to further build upon their existing collaborative efforts to co-develop and market innovative new products and tools for people living with diabetes.
MILPITAS, Calif., May 9, 2011 /PRNewswire/ -- LifeScan, Inc., makers of the top-selling OneTouchÂ® Brand of Blood Glucose Monitoring Systems for people with diabetes, has fulfilled the terms of its exclusive, three-year agreement to provide Medtronic customers in the U.S.
DALLAS, November 25, 2010 /PRNewswire/ -- ReportsandReports announces it will carry Infusion Pump Markets (Large Volume, Ambulatory, Insulin, Enteral and Other Pumps) Research Report in its store. Browse the complete Report on: http://www.reportsandreports.com/reports/35298-infusion-pump-markets-large- volume-ambulatory-insulin-enteral.html Browse All Healthcare Reports: http://www.reportsandreports.com/cat/healthcare-market-research.html Search More Then 50000 Market Research...
SANTA BARBARA, Calif., June 25 /PRNewswire/ -- The University of California Santa Barbara (UCSB) and Sansum Diabetes Research Institute (Sansum) announced today the achievement of a milestone in the Artificial Pancreas Project funded by the Juvenile Diabetes Research Foundation (JDRF). The world's most flexible artificial pancreas system platform, currently being used in clinical trials around the globe, now has the benefit of compatibility with Animas Corporation insulin delivery products.
- A political dynamiter.